Understanding the quality of life (QOL) issues in survivors of cancer: Towards the development of an EORTC QOL cancer survivorship questionnaire

Health and Quality of Life Outcomes

Volumn 16, Issue 1, 2018, Pages

  van Leeuwen, Marieke ^a   Husson, Olga ^b   Alberti, Paola ^c   Arraras, Juan Ignacio ^d   Chinot, Olivier L ^e   Costantini, Anna ^f   Darlington, Anne Sophie ^g   Dirven, Linda ^h,i   Eichler, Martin ^j   Hammerlid, Eva B ^k   Holzner, Bernhard ^l   Johnson, Colin D ^m   Kontogianni, Meropi ⁿ   Kjær, Trille Kristina ^o   Morag, Ofir ^p   Nolte, Sandra ^q   Nordin, Andrew ^r   Pace, Andrea ^s   Pinto, Monica ^t   Polz, Katja ^u   Ramage, John ^v   Reijneveld, Jaap C ^w   Serpentini, Samantha ^x   Tomaszewski, Krzysztof A ^y   Vassiliou, Vassilios ^z   Verdonck de Leeuw, Irma M ^w   Vistad, Ingvild ^aa   Young, Teresa E ^ab   Aaronson, Neil K ^a   van de Poll Franse, Lonneke V ^a,ac,ad   more..

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d Instituto de Investigación Sanitaria de Navarra   (Spain)

^e AIX MARSEILLE UNIVERSITY   (France)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ MEDICAL CENTER HAAGLANDEN   (Netherlands)

^j UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^k SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^l INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^m UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

ⁿ HAROKOPIO UNIVERSITY   (Greece)

^o DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^p SHEBA MEDICAL CENTER   (Israel)

^q CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^r East Kent Gynaecological Oncology Centre   (United Kingdom)

^s REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^t NATIONAL CANCER INSTITUTE   (Italy)

^u Centre for Hygiene   (Germany)

^v BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^w VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^x VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^y Ignatianum Academy   (Poland)

^z Bank of Cyprus Group Oncology Centre   (Cyprus)

^aa Sørlandet Hospital Kristiansand   (Norway)

^ab MOUNT VERNON CANCER CENTRE   (United Kingdom)

^ac Eindhoven Cancer Registry   (Netherlands)

^ad TILBURG UNIVERSITY   (Netherlands)

more..

Author keywords

Cancer survivor; Disease free; Health related quality of life; Oncology; Survivorship questionnaire

Indexed keywords

ADULT; ARTICLE; BODY IMAGE; CANCER LOCALIZATION; CANCER SURVIVOR; COGNITION; CONTROLLED STUDY; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; EUROPE; FATIGUE; FEMALE; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MENTAL HEALTH; MIDDLE AGED; NAUSEA; ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER QUESTIONNAIRE; PAIN; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; SEXUAL DYSFUNCTION; SLEEP DISORDER; SOCIAL STATUS; SURVIVORSHIP; AGED; DAILY LIFE ACTIVITY; NEOPLASM; PATIENT-REPORTED OUTCOME; PSYCHOLOGY; TIME FACTOR;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; CANCER SURVIVORS; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT REPORTED OUTCOME MEASURES; QUALITY OF LIFE; SURVIVORSHIP; TIME FACTORS;

EID: 85048047667     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-018-0920-0     Document Type: Article

References (47)

1. Ayanian JZ, Jacobsen PB. Enhancing research on cancer survivors. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24:5149-53.
2. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, De Haes JC. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-76.
3. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-9.
4. Zhao L, Portier K, Stein K, Baker F, Smith T. Exploratory factor analysis of the cancer problems in living scale: a report from the American Cancer Society's studies of cancer survivors. J Pain Symptom Manag. 2009;37:676-86.
5. Baker F, Denniston M, Zabora JR, Marcellus D. Cancer problems in living and quality of life after bone marrow transplantation. J Clin Psychol Med Settings. 2003;10:27.
6. Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L. Assessing the impact of cancer: development of a new instrument for long-term survivors. Psychooncology. 2006;15:407-21.
7. Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B. Refinement and psychometric evaluation of the impact of cancer scale. J Natl Cancer Inst. 2008;100:1530-41.
8. Crespi CM, Ganz PA, Petersen L, Smith SK. A procedure for obtaining impact of cancer version 2 scores using version 1 responses. Qual Life Res. 2013;22:103-9.
9. Avis NE, Ip E, Foley KL. Evaluation of the quality of life in adult cancer survivors (QLACS) scale for long-term cancer survivors in a sample of breast cancer survivors. Health Qual Life Outcomes. 2006;4:92.
10. Avis NE, Smith KW, McGraw S, Smith RG, Petronis VM, Carver CS. Assessing quality of life in adult cancer survivors (QLACS). Qual Life Res. 2005;14:1007-23.
11. Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4:523-31.
12. Baker F, Denniston M, Hann D, Gesme D, Reding DJ, Flynn T, Kennedy JS. Factor structure and concurrent validity of the satisfaction with life domains scale for Cancer (SLDS-C). J Psychosoc Oncol. 2007;25:1-17.
13. Muzzatti B, Annunziata MA. Assessing quality of life in long-term cancer survivors: a review of available tools. Support Care Cancer. 2013;21:3143-52.
14. Marzorati C, Riva S, Pravettoni G. Who is a cancer survivor? A systematic review of published definitions. J Cancer Educ. 2017;32:228-37.
15. Stewart AL, Ware JE, Jr. Measuring functioning and well-being: the medical outcomes study approach. Durham and London: Duke University Press; 1992.
16. Johnson C, Aaronson N, Blazeby JM, Bottomley A, Fayers P, Koller M, Kuliś D, Ramage G, Sprangers M, Velikova G, Young T: Guidelines for developing questionnaire modules. 2011.
17. Kumthekar P, Raizer J, Singh S. Low-grade glioma. Cancer Treat Res. 2015;163:75-87.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
19. Van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008;44:2418-24.
20. Greimel E, Bottomley A, Cull A, Waldenstrom AC, Arraras J, Chauvenet L, Holzner B, Kuljanic K, Lebrec J, D'Haese S. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer. 2003;39:1402-8.
21. Greimel E, Nordin A, Lanceley A, Creutzberg CL, van de Poll-Franse LV, Radisic VB, Galalae R, Schmalz C, Barlow E, Jensen PT, et al. Psychometric validation of the European organisation for research and treatment of cancer quality of life questionnaire-endometrial cancer module (EORTC QLQ-EN24). Eur J Cancer. 2011;47:183-90.
22. Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, Duric VM, Jensen PT, Singer S, Chie W, Nordin A, Bjelic Radisic V, Wydra D. The European Organization for Research and Treatment of Cancer (EORTC) quality-of-life questionnaire cervical cancer module: EORTC QLQ-CX24. Cancer. 2006;107:1812-22.
23. Holzner B, Efficace F, Basso U, Johnson CD, Aaronson NK, Arraras JI, Smith AB, Chow E, Oberguggenberger AS, Bottomley A, et al. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Qual Life Res. 2013;22:369-78.
24. Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14:2756-68.
25. Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff RO, van den Bent MJ, Bottomley A. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer. 2010;46:1033-40.
26. Whistance RN, Conroy T, Chie W, Costantini A, Sezer O, Koller M, Johnson CD, Pilkington SA, Arraras J, Ben Josef E, et al. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer. 2009;45:3017-26.
27. Bjordal K, De Graeff A, Fayers PM, Hammerlid E, Van Pottelsberghe C, Curran D, Ahlner-Elmqvist M, Maher EJ, Meyza JW, Brédart A, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Cancer. 2000;36:1796-807.
28. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC study group on quality of life. Eur J Cancer. 1994;30a:635-42.
29. Blazeby JM, Hall E, Aaronson NK, Lloyd L, Waters R, Kelly JD, Fayers P. Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer. Eur Urol. 2014;66:1148-56.
30. Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, et al. International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24. Qual Life Res. 2014;23:825-36.
31. van de Poll-Franse L, Oerlemans S, Bredart A, Kyriakou C, Sztankay M, Pallua S, Daniels L, Creutzberg CL, Cocks K, Malak S, et al. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia. Qual Life Res. 2018;27:333-45.
32. Cocks K, Cohen D, Wisloff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer. 2007;43:1670-8.
33. Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods. 2006;5:80-92.
34. NVivo qualitative data analysis Software. 10th ed. QSR International Pty Ltd.; 2012.
35. Knobf MT. Reproductive and hormonal sequelae of chemotherapy in women. Premature menopause and impaired fertility can result, effects that are especially disturbing to young women. Am J Nurs. 2006;106:60-5.
36. Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD. Functional impact of breast cancer by age at diagnosis. J Clin Oncol. 2004;22:1849-56.
37. Wenzel LB, Fairclough DL, Brady MJ, Cella D, Garrett KM, Kluhsman BC, Crane LA, Marcus AC. Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer. 1999;86:1768-74.
38. Norton T, Manne S, Rubin S, Hernandez E, Carlson J, Bergman C, Rosenblum N. Ovarian Cancer Patients' psychological distress: the role of physical impairment, perceived unsupportive family and friend behaviors, perceived control, and self-esteem. Health Psychol. 2005;24:143-52.
39. Bodurka-Bevers D, Basen-Engquist K, Carmack CL, Fitzgerald MA, Wolf JK, De Moor C, Gershenson DM. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol. 2000;78:302-8.
40. Fitch M, Gray RE, Franssen E. Perspectives on living with ovarian cancer: young women's views. Can Oncol Nurs J. 2000;10:101-8.
41. Stanton AL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol. 2012;30:1215-20.
42. Petersen MA, Groenvold M, Aaronson NK, Chie WC, Conroy T, Costantini A, Fayers P, Helbostad J, Holzner B, Kaasa S, et al. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning. Eur J Cancer. 2010;46:1352-8.
43. Mayer DK, Nasso SF, Earp JA. Defining cancer survivors, their needs, and perspectives on survivorship health care in the USA. Lancet Oncol. 2017;18:e11-8.
44. Stanton AL, Ganz PA, Rowland JH, Meyerowitz BE, Krupnick JL, Sears SR. Promoting adjustment after treatment for cancer. Cancer. 2005;104:2608-13.
45. van der Poel MW, Oerlemans S, Schouten HC, Mols F, Pruijt JF, Maas H, van de Poll-Franse LV. Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry. Ann Hematol. 2014;93:811-9.
46. van der Poel MW, Oerlemans S, Schouten HC, van de Poll-Franse LV. Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry. Ann Hematol. 2015;94:651-61.
47. SEER Cancer Statistics Review, 1975-2014. Bethesda: National Cancer Institute; 2016.